A clinical study of the metabolic effect of a new oral hypoglycemic agent: glipizide.
D000328:Adult; D000368:Aged; D001786:Blood Glucose; D002940:Circadian Rhythm; D003510:Cyclohexanes / Q000494:pharmacology; D003920:Diabetes Mellitus / Q000097:blood / Q000188:drug therapy; D005260:Female; D006029:Glycosuria; D013006:Growth Hormone / Q000097:blood; D006801:Humans; D007004:Hypoglycemic Agents / Q000494:pharmacology*; D007328:Insulin / Q000097:blood; D008297:Male; D008875:Middle Aged; D011719:Pyrazines / Q000494:pharmacology; D013453:Sulfonylurea Compounds / Q000494:pharmacology* / Q000627:therapeutic use; D014044:Tolbutamide / Q000627:therapeutic use
D001786:Blood Glucose; D003510:Cyclohexanes; D007004:Hypoglycemic Agents; D007328:Insulin; D011719:Pyrazines; D013453:Sulfonylurea Compounds; D013006:Growth Hormone; D014044:Tolbutamide